000 | 01513 a2200421 4500 | ||
---|---|---|---|
005 | 20250511183704.0 | ||
264 | 0 | _c19921201 | |
008 | 199212s 0 0 eng d | ||
022 | _a0014-2999 | ||
024 | 7 |
_a10.1016/0014-2999(92)90748-s _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFink-Jensen, A | |
245 | 0 | 0 |
_aThe gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. _h[electronic resource] |
260 |
_bEuropean journal of pharmacology _cSep 1992 |
||
300 |
_a197-201 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 |
_aGlobus Pallidus _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNipecotic Acids _xadministration & dosage |
650 | 0 | 4 |
_aPentylenetetrazole _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSeizures _xchemically induced |
650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
650 | 0 | 4 | _aTiagabine |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
700 | 1 | _aSuzdak, P D | |
700 | 1 | _aSwedberg, M D | |
700 | 1 | _aJudge, M E | |
700 | 1 | _aHansen, L | |
700 | 1 | _aNielsen, P G | |
773 | 0 |
_tEuropean journal of pharmacology _gvol. 220 _gno. 2-3 _gp. 197-201 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(92)90748-s _zAvailable from publisher's website |
999 |
_c1432482 _d1432482 |